Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Stem Cell Lab Planned for Commercial Space Station

Orbital Reef

A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station. . . . → Read More: Stem Cell Lab Planned for Commercial Space Station

Exec. Order Aims to Boost U.S. Biotech, Manufacturing

White House, Lafayette Square

An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing

Venture to Build Cell, Gene Therapy Businesses

Gene therapy graphic

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Brewer's yeast

A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Ginkgo Acquires Biomaterials Maker as Industry Consolidates

Digital DNA

A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates

Trial Okayed for Engineered Cell Cancer Therapy

Tumor infiltrating lymphocyte

A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins. . . . → Read More: Trial Okayed for Engineered Cell Cancer Therapy

Precision Antibacterial Company Raises $35M in New Funds

E. coli bacteria

A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds

Trial Set for Gut Infection Biologic Treatment

C. difficile in petri dish

A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile. . . . → Read More: Trial Set for Gut Infection Biologic Treatment

New Industry, Academic Studies Arrive at Space Station

International Space Station

Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station

Electric Future of the Global Supply Chain

Several global issues contribute to the current international trade and manufacturing situation. . . . → Read More: Electric Future of the Global Supply Chain